Pharmacogenomics of Maternal Tobacco Use
- 1 March 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 115 (3), 568-577
- https://doi.org/10.1097/aog.0b013e3181d06faf
Abstract
OBJECTIVE: To assess whether functional maternal or fetal genotypes along well-characterized metabolic pathways (ie, CYP1A1, GSTT1, and CYP2A6) may account for varying associations with adverse outcomes among pregnant women who smoke. METHODS: DNA samples from 502 smokers and their conceptuses, alongside women in a control group, were genotyped for known functional allelic variants of CYP1A1 (Ile462Val AA>AG/GG), GSTT1(del), and CYP2A6 (Lys160His T>A). Modification of the association between smoking and outcome by genotype was evaluated. Outcomes included birth weight, pregnancy loss, preterm birth, small for gestational age, and a composite outcome composed of the latter four components plus abruption. RESULTS: No interaction between maternal or fetal genotype of any of the polymorphisms and smoking could be demonstrated. In contrast, the association of smoking with gestational age–adjusted birth weight (birth weight ratio) was modified by fetal GSTT1 genotype (P for interaction=.02). Fetuses with GSTT1(del) had a mean birth weight reduction among smokers of 262 g (P=.01), whereas in fetuses without the GSTT1(del) the effect of tobacco exposure was nonsignificant (mean reduction 87 g, P=.16). After adjusting for confounding, results were similar. CONCLUSION: Fetal GSTT1 deletion significantly and specifically modifies the effect of smoking on gestational age–corrected birth weight. LEVEL OF EVIDENCE: IIKeywords
This publication has 41 references indexed in Scilit:
- Sample Bias Among Women With Retained DNA Samples for Future Genetic StudiesObstetrics & Gynecology, 2006
- CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lungCarcinogenesis: Integrative Cancer Research, 2005
- CYP1A1 Val 462 and NQO1 Ser 187 polymorphisms, cigarette use, and risk for colorectal adenomaCarcinogenesis: Integrative Cancer Research, 2005
- Maternal Smoking, Intrauterine Growth Restriction, and Placental ApoptosisPediatric and Developmental Pathology, 2004
- Polymorphisms of CYP2A6 and its practical consequencesBritish Journal of Clinical Pharmacology, 2001
- Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolismFEBS Letters, 1999
- The Influence of Gestational Age and Smoking Habits on the Risk of Subsequent Preterm DeliveriesNew England Journal of Medicine, 1999
- A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblastInternational Journal of Gynecology & Obstetrics, 1998
- DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant statusZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Aryl hydrocarbon hydroxylase activity in human placenta of passive smokersEnvironmental Research, 1989